Paean Biotechnology Inc.
2 clinical trials · Sponsor
◉ Watch Paean Biotechnology Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis (NCT07122648) | Paean Biotechnology Inc. | 2025-12-01 |
| Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis (NCT04976140) | Paean Biotechnology Inc. | 2021-12-15 |
Track Paean Biotechnology Inc. automatically
Every clearance here is in the API, with alerts when new ones post.